DEVELOPMENT AND VALIDATION OF A SIZE EXCLUSION CHROMATOGRAPHY METHOD FOR DETERMINATION OF MOLECULAR MASSES AND MOLECULAR MASS-DISTRIBUTION IN LOW-MOLECULAR-WEIGHT HEPARIN

被引:35
作者
KRISTENSEN, HI
TROMBORG, EM
NIELSEN, JR
NIELSEN, JI
JOHANSEN, KB
OSTERGAARD, PB
机构
[1] LEO PHARMACEUT PROD,CHEM CONTROL LAB,DK-2750 BALLERUP,DENMARK
[2] LEO PHARMACEUT PROD,HEPARIN RES LAB,DK-2750 BALLERUP,DENMARK
关键词
LMW HEPARIN; HEPARIN; MOLECULAR MASS DISTRIBUTION; SIZE EXCLUSION CHROMATOGRAPHY;
D O I
10.1016/0049-3848(91)90113-B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A precise and rugged high performance size exclusion chromatography (HPSEC) method for determination of peak maximum molecular mass (M(p)), weight average molecular mass (M(w)), number average molecular mass (M(n)), and molecular mass distribution (MMD) in Low Molecular Weight heparin (LMW heparin) has been developed and validated on two Ultrahydrogel(R) 250 (ID 7, 8 mm, length 30 cm) columns in series at three laboratories using different equipment. The calibration is based on four local laboratory heparin standards with relatively narrow molecular mass distribution and M(p) covering the range from 3,000 to 17,000 Da. The calibration curve describing the logarithm of the molecular mass versus retention time is linear in the range 3,000 to 17,000 Da. The precision (relative standard deviation) within-run and between-run is better than 2%. The between-laboratory variation is below 5%, 3% and 8% for M(p), M(w) and M(n), respectively. This method is reproducible, rugged, and fast and is suited for the determination of average molecular masses and molecular mass distribution of LMW heparins on a routine basis.
引用
收藏
页码:131 / 141
页数:11
相关论文
共 15 条
[1]   COMPARATIVE PHARMACOKINETICS OF A LOW-MOLECULAR WEIGHT HEPARIN (PK-10-169) AND UNFRACTIONATED HEPARIN AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION [J].
BARA, L ;
BILLAUD, E ;
GRAMOND, G ;
KHER, A ;
SAMAMA, M .
THROMBOSIS RESEARCH, 1985, 39 (05) :631-636
[2]  
BATSBERG W, 1988, 8TH INT S HPLC PROT
[3]   LOW-MOLECULAR-WEIGHT HEPARIN (KABI-2165, FRAGMIN) - PHARMACOKINETICS AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HUMAN VOLUNTEERS [J].
BRATT, G ;
TORNEBOHM, E ;
WIDLUND, L ;
LOCKNER, D .
THROMBOSIS RESEARCH, 1986, 42 (05) :613-620
[5]   CHEMICAL AND BIOLOGICAL HETEROGENEITY IN LOW-MOLECULAR WEIGHT HEPARINS - IMPLICATIONS FOR CLINICAL USE AND STANDARDIZATION [J].
FAREED, J ;
WALENGA, JM ;
HOPPENSTEADT, D ;
RACANELLI, A ;
COYNE, E .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1989, 15 (04) :440-463
[6]   CHARACTERIZATION OF HEPARINS BY HIGH-PERFORMANCE SIZE EXCLUSION LIQUID-CHROMATOGRAPHY [J].
HARENBERG, J ;
DEVRIES, JX .
JOURNAL OF CHROMATOGRAPHY, 1983, 261 (02) :287-292
[7]   STANDARDIZATION OF HEPARINS BY MEANS OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY EQUIPPED WITH A LOW-ANGLE LASER-LIGHT SCATTERING DETECTOR [J].
HENNINK, WE ;
VANDENBERG, JWA ;
FEIJEN, J .
THROMBOSIS RESEARCH, 1987, 45 (05) :463-475
[8]  
MATZSCH T, 1987, THROMB HAEMOSTASIS, V57, P97
[9]   THE MOLECULAR-WEIGHT DISTRIBUTION OF HEPARIN DETERMINED WITH A HPLC-LALLS COUPLING TECHNIQUE [J].
MIKLAUTZ, H ;
RIEMANN, J ;
VIDIC, HJ .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1986, 9 (10) :2073-2093
[10]   HIGH-PRESSURE SIZE-EXCLUSION CHROMATOGRAPHY OF ANTICOAGULANT MATERIALS [J].
MULLER, D ;
NDOUMENZE, M ;
JOZEFONVICZ, J .
JOURNAL OF CHROMATOGRAPHY, 1984, 297 (AUG) :351-358